Filing Details

Accession Number:
0001209191-20-062229
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-08 16:01:36
Reporting Period:
2020-12-04
Accepted Time:
2020-12-08 16:01:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1446847 Ironwood Pharmaceuticals Inc IRWD Pharmaceutical Preparations (2834) 043404176
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1781117 Kelly Macdonald C/o Ironwood Pharmaceuticals, Inc.
100 Summer Street, Suite 2300
Boston MA 02110
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2020-12-04 5,639 $9.12 98,680 No 4 M Direct
Class A Common Stock Disposition 2020-12-04 5,639 $12.50 93,041 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (Right to Buy) Disposition 2020-12-04 5,639 $0.00 5,639 $9.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-03-01 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This option, granted as an annual performance award, is presently exercisable in full.